Bhagiradha Chemicals & Industries Ltd

Bhagiradha Chem. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Bhagiradha Chemicals & Industries Ltd

₹ 230 -7.79%
19 Dec - close price
bhagirad.com BSE: 531719 NSE: BHAGCHEM
About

Bhagiradha Chemicals & Industries is an Agro Chemical Company in India involved in the manufacturing of insecticides, fungicides, herbicides etc. It was Promoted by late Sri S. Koteswara Rao, a former scientist of Indian Institute of Chemical Technology, Hyderabad in the year 1993.[1][2]

Key Points

Product Portfolio (32 Active Ingredients)[1]
The company's product portfolio includes a wide range of insecticides, fungicides, herbicides, and specialty intermediaries
a. Insecticides: Chlorpyrifos, Diafenthiuron, Fipronil, Buprofezin, etc.
b. Fungicides: Azoxystrobin
c. Herbicides: Imazethapyr, Clodinafop-propargyl, Cloquintocet-mexyl
d. Specialty-intermediaries: R-HPPA, 2,6-Dichloroaniline, etc [2]

Website BSE NSE
  • Market Cap ₹ 2,976 Cr.
  • Current Price ₹ 230
  • High / Low ₹ 331 / 222
  • Stock P/E 244
  • Book Value ₹ 53.2
  • Dividend Yield 0.07 %
  • ROCE 5.19 %
  • ROE 2.53 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Stock is trading at 4.32 times its book value
  • Promoter holding is low: 19.6%
  • Company has a low return on equity of 6.64% over last 3 years.
  • Company might be capitalizing the interest cost
  • Dividend payout has been low at 9.66% of profits over last 3 years
  • Debtor days have increased from 111 to 144 days.
  • Promoter holding has decreased over last 3 years: -4.84%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals

Part of BSE SmallCap BSE Allcap BSE Commodities

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
131.81 126.00 122.57 100.01 122.01 74.37 111.25 111.39 103.73 102.73 122.62 123.78 140.10
111.62 106.68 104.35 92.91 108.55 66.09 97.17 99.40 94.02 93.57 116.55 114.79 125.04
Operating Profit 20.19 19.32 18.22 7.10 13.46 8.28 14.08 11.99 9.71 9.16 6.07 8.99 15.06
OPM % 15.32% 15.33% 14.86% 7.10% 11.03% 11.13% 12.66% 10.76% 9.36% 8.92% 4.95% 7.26% 10.75%
0.37 0.50 0.22 0.32 0.13 0.76 1.47 2.27 3.25 2.45 1.32 0.64 0.46
Interest 0.82 0.85 1.55 1.72 2.27 1.56 2.14 1.34 1.77 2.45 1.55 3.26 4.06
Depreciation 2.43 2.47 2.58 2.63 2.81 2.68 2.85 3.25 3.41 3.61 3.60 3.87 3.95
Profit before tax 17.31 16.50 14.31 3.07 8.51 4.80 10.56 9.67 7.78 5.55 2.24 2.50 7.51
Tax % 29.46% 29.33% 34.38% 35.83% 32.67% 30.83% 31.63% 41.05% 30.08% 35.32% 139.73% -58.80% 26.76%
12.21 11.65 9.39 1.97 5.72 3.32 7.22 5.71 5.44 3.59 -0.88 3.98 5.50
EPS in Rs 1.17 1.12 0.90 0.19 0.55 0.32 0.69 0.46 0.44 0.29 -0.07 0.31 0.42
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
246 318 436 502 408 440 489
229 271 367 425 365 404 450
Operating Profit 17 47 68 77 43 37 39
OPM % 7% 15% 16% 15% 11% 8% 8%
4 2 1 1 3 9 5
Interest 5 8 9 5 8 7 11
Depreciation 7 8 9 10 11 14 15
Profit before tax 9 32 51 64 27 25 18
Tax % 27% 27% 30% 29% 32% 45%
7 23 36 45 18 14 12
EPS in Rs 0.63 2.27 3.48 4.34 1.75 1.07 0.95
Dividend Payout % 0% 0% 7% 9% 6% 14%
Compounded Sales Growth
10 Years: %
5 Years: 12%
3 Years: 0%
TTM: 22%
Compounded Profit Growth
10 Years: %
5 Years: 22%
3 Years: -27%
TTM: -44%
Stock Price CAGR
10 Years: 37%
5 Years: 46%
3 Years: 21%
1 Year: -28%
Return on Equity
10 Years: %
5 Years: 9%
3 Years: 7%
Last Year: 3%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 8 8 8 10 10 13 13
Reserves 124 147 182 303 403 669 677
43 62 81 50 62 89 189
50 55 71 83 101 162 161
Total Liabilities 225 273 342 447 576 933 1,040
138 152 157 173 214 245 256
CWIP 4 2 5 28 68 289 377
Investments 0 0 0 0 38 0 0
83 119 181 246 256 399 406
Total Assets 225 273 342 447 576 933 1,040

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
48 4 7 14 34 -53
-39 -21 -17 -60 -116 -200
-9 15 12 46 88 272
Net Cash Flow 0 -2 2 1 7 19

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 17 68 81 94 96 144
Inventory Days 137 97 91 108 168 173
Days Payable 59 89 73 69 98 125
Cash Conversion Cycle 95 76 99 132 166 193
Working Capital Days -12 21 32 90 94 124
ROCE % 20% 25% 22% 8% 5%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
23.52% 23.52% 23.52% 23.52% 23.52% 23.52% 20.27% 20.27% 20.27% 19.75% 19.75% 19.60%
0.10% 0.10% 0.12% 0.10% 0.17% 0.16% 0.17% 0.15% 0.18% 0.04% 0.05% 0.05%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 3.14% 3.14% 3.08% 2.89% 2.89% 2.89%
76.39% 76.39% 76.37% 76.38% 76.32% 76.33% 76.42% 76.44% 76.46% 77.33% 77.31% 77.48%
No. of Shareholders 3,4653,4083,5243,9413,7474,29211,29815,10114,76213,88313,91113,761

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls

  • Nov 2025
    Transcript
    AI Summary
    PPT
  • Aug 2025
    Transcript
    AI Summary
    PPT
  • May 2025
    Transcript
    AI Summary
    PPT
  • Feb 2025
    Transcript
    AI Summary
    PPT
  • Nov 2024
    Transcript
    AI Summary
    PPT